跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 145 条关于
“Aiolos (IKZF3)”
全部
145
临床试验
94
药物
10
机构
5
资讯
36
去年
Kangpu's Novel Molecular Glue Modulator KPG-818 Receives IND Approval in China for Multiple Myeloma Treatment
10个月前
Kangpu's Novel Cereblon Modulator Shows 50% Response Rate in Heavily Pre-treated Multiple Myeloma Patients
上个月
The Second Act of Thalidomide: From Teratogen to the Foundation of Targeted Protein Degradation
去年
Nurix Therapeutics Advances BTK Degrader NX-5948 and Reinitiates NX-2127 Trial
去年
Nurix Therapeutics' BTK Degrader NX-5948 Shows Promise in B-Cell Malignancies and Autoimmune Diseases
2年前
GSK Acquires Aiolos Bio for $1.4B, Expanding Asthma Treatment Portfolio with Novel TSLP Inhibitor
2年前
Investors Launch $400M Hercules Startup to Develop Novel GLP-1 Therapies for Obesity and Diabetes
5个月前
Beeline Medicines Emerges with $300M Series A and Bristol Myers' Immune Disease Pipeline
去年
Forbion Secures €2 Billion in Landmark Biotech Investment Funds
2年前
Nurix Therapeutics Outlines 2024 Strategic Priorities with Focus on Cancer and Autoimmune Diseases
第 1 页,共 4 页
上一页
下一页